泊马度胺
医学
无容量
多发性骨髓瘤
耐火材料(行星科学)
肿瘤科
内科学
来那度胺
材料科学
免疫疗法
癌症
复合材料
作者
Albert Oriol,Roman Hájek,Ivan Špıčka,Irwindeep Sandhu,Yaël Cohen,Moshe E. Gatt,José Mariz,Michèle Cavo,Jesús G. Berdeja,Kexin Jin,Merav Bar,Prianka Das,Ross La Motte-Mohs,Yu Wang,Deepak Perumal,Luciano J. Costa
标识
DOI:10.1016/j.clml.2024.05.014
摘要
Preclinical studies suggest that combining nivolumab, a programmed death-1 (PD-1) immune checkpoint inhibitor, with pomalidomide/dexamethasone (Pd) with or without elotuzumab, an antisignaling lymphocytic activation molecule F7 monoclonal antibody, may improve multiple myeloma (MM) treatment efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI